144 related articles for article (PubMed ID: 29987426)
1. Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus.
Hou C; Jin O; Zhang X
Clin Rheumatol; 2018 Oct; 37(10):2699-2705. PubMed ID: 29987426
[TBL] [Abstract][Full Text] [Related]
2. Hematocrit Level could Reflect Inflammatory Response and Disease Activity in Patients with Systemic Lupus Erythematosus.
Yang M; Ma N; Fu H; Wei T; Tang Q; Qin B; Yang Z; Zhong R
Clin Lab; 2015; 61(7):801-7. PubMed ID: 26299080
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 15 patients with systemic lupus erythematosus manifesting with negative immunofluorescence anti-nuclear antibodies after treatment.
Song LJ; Ding F; Liu HX; Shu Q; Yu X; Li J; Li XF
Lupus; 2012 Jul; 21(8):919-24. PubMed ID: 22187164
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
[TBL] [Abstract][Full Text] [Related]
6. The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.
Littlejohn E; Marder W; Lewis E; Francis S; Jackish J; McCune WJ; Somers EC
Lupus; 2018 Jun; 27(7):1123-1129. PubMed ID: 29546774
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.
Firooz N; Albert DA; Wallace DJ; Ishimori M; Berel D; Weisman MH
Lupus; 2011 May; 20(6):588-97. PubMed ID: 21436216
[TBL] [Abstract][Full Text] [Related]
8. Cell-bound complement activation products associate with lupus severity in SLE.
Arriens C; Alexander RV; Narain S; Saxena A; Collins CE; Wallace DJ; Massarotti E; Conklin J; Kalunian KC; Putterman C; Ramsey-Goldman R; Buyon JP; Askanase A; Furie RA; James JA; Bello GA; Manzi S; Ahearn J; O'Malley T; Weinstein A; Dervieux T
Lupus Sci Med; 2020 Apr; 7(1):. PubMed ID: 32371480
[TBL] [Abstract][Full Text] [Related]
9. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
10. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.
Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J
QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779
[TBL] [Abstract][Full Text] [Related]
11. [Role of C-reactive protein in systemic lupus erythematosus].
Cengić M; Heljić B; Rasić S; Dilić M
Med Arh; 2002; 56(3):147-9. PubMed ID: 12378859
[TBL] [Abstract][Full Text] [Related]
12. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus.
Li H; Lin S; Yang S; Chen L; Zheng X
Clin Rheumatol; 2015 Mar; 34(3):471-7. PubMed ID: 25597615
[TBL] [Abstract][Full Text] [Related]
14. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
15. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.
Rúa-Figueroa Í; López-Longo J; Galindo-Izquierdo M; Calvo-Alén J; Del Campo V; Olivé-Marqués A; Pérez-Vicente S; Fernández-Nebro A; Andrés M; Erausquin C; Tomero E; Horcada L; Uriarte E; Freire M; Montilla C; Sánchez-Atrio A; Santos G; Boteanu A; Díez-Álvarez E; Narváez J; Martínez-Taboada V; Silva-Fernández L; Ruiz-Lucea E; Andreu JL; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pérez-Venegas J; Pecondón-Español Á; Marras C; Ibáñez-Barceló M; Bonilla G; Torrente V; Castellví I; Alegre JJ; Calvet J; Marenco JL; Raya E; Vázquez T; Quevedo V; Muñoz-Fernández S; Rodríguez-Gómez M; Ibáñez J; Pego-Reigosa JM
Semin Arthritis Rheum; 2017 Aug; 47(1):38-45. PubMed ID: 28259425
[TBL] [Abstract][Full Text] [Related]
16. Does erythrocyte sedimentation rate reflect and discriminate flare from infection in systemic lupus erythematosus? Correlation with clinical and laboratory parameters of disease activity.
Schäfer VS; Weiß K; Krause A; Schmidt WA
Clin Rheumatol; 2018 Jul; 37(7):1835-1844. PubMed ID: 29656375
[TBL] [Abstract][Full Text] [Related]
17. [Hematological abnormalities in systemic lupus erythematosus and clinical significance thereof: comparative analysis of 236 cases].
Chen JL; Huang XM; Zeng XJ; Wang Y; Zhou MX; Ma YH; Li RS; Shen T
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1330-3. PubMed ID: 17727778
[TBL] [Abstract][Full Text] [Related]
18. Mortality prediction in systemic lupus erythematosus patients with pulmonary infection.
Lu Z; Li J; Ji J; Gu Z; Da Z
Int J Rheum Dis; 2019 Jun; 22(6):1077-1083. PubMed ID: 30968568
[TBL] [Abstract][Full Text] [Related]
19. Hyponatremia in patients with systemic lupus erythematosus.
Il Shin J; Park SJ; Suh CH; Lee GH; Hur MW; Han SY; Kim DS; Kim JH
Sci Rep; 2016 May; 6():25566. PubMed ID: 27193532
[TBL] [Abstract][Full Text] [Related]
20. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
